Combined haploidentical and cord blood transplantation for refractory severe aplastic anaemia and hypoplastic myelodysplastic syndromeRichard Childs, Georg Aue, Xin Tian et al.|British Journal of Haematology|2021Cited by 12
Preliminary safety, pharmacokinetics and clinical activity of DFF332, an oral HIF2α inhibitor, as monotherapy in a phase 1 dose escalation study in patients with advanced clear cell renal cell carcinoma.Sumanta Kumar Pal, Laurence Albigès, Ritesh R. Kotecha et al.|Journal of Clinical Oncology|2024Cited by 9